Logo image of ATEME.PA

ATEME SA (ATEME.PA) Stock Fundamental Analysis

EPA:ATEME - Euronext Paris - Matif - FR0011992700 - Common Stock - Currency: EUR

4.06  +0.03 (+0.74%)

Fundamental Rating

3

Overall ATEME gets a fundamental rating of 3 out of 10. We evaluated ATEME against 23 industry peers in the Communications Equipment industry. Both the profitability and financial health of ATEME have multiple concerns. ATEME is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ATEME has reported negative net income.
ATEME had a positive operating cash flow in the past year.
ATEME had negative earnings in 4 of the past 5 years.
In multiple years ATEME reported negative operating cash flow during the last 5 years.
ATEME.PA Yearly Net Income VS EBIT VS OCF VS FCFATEME.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M -6M

1.2 Ratios

The Return On Assets of ATEME (-4.54%) is comparable to the rest of the industry.
ATEME has a Return On Equity (-16.00%) which is in line with its industry peers.
Industry RankSector Rank
ROA -4.54%
ROE -16%
ROIC N/A
ROA(3y)-2.76%
ROA(5y)-1.47%
ROE(3y)-8.87%
ROE(5y)-4.9%
ROIC(3y)N/A
ROIC(5y)N/A
ATEME.PA Yearly ROA, ROE, ROICATEME.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

ATEME's Gross Margin of 57.97% is fine compared to the rest of the industry. ATEME outperforms 69.57% of its industry peers.
In the last couple of years the Gross Margin of ATEME has remained more or less at the same level.
ATEME does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.28%
GM growth 5Y1.27%
ATEME.PA Yearly Profit, Operating, Gross MarginsATEME.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

ATEME does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ATEME has been increased compared to 1 year ago.
Compared to 5 years ago, ATEME has more shares outstanding
Compared to 1 year ago, ATEME has an improved debt to assets ratio.
ATEME.PA Yearly Shares OutstandingATEME.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ATEME.PA Yearly Total Debt VS Total AssetsATEME.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of 1.35, we must say that ATEME is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ATEME (1.35) is comparable to the rest of the industry.
The Debt to FCF ratio of ATEME is 17.15, which is on the high side as it means it would take ATEME, 17.15 years of fcf income to pay off all of its debts.
ATEME's Debt to FCF ratio of 17.15 is on the low side compared to the rest of the industry. ATEME is outperformed by 60.87% of its industry peers.
ATEME has a Debt/Equity ratio of 0.74. This is a neutral value indicating ATEME is somewhat dependend on debt financing.
The Debt to Equity ratio of ATEME (0.74) is worse than 60.87% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 17.15
Altman-Z 1.35
ROIC/WACCN/A
WACC5.12%
ATEME.PA Yearly LT Debt VS Equity VS FCFATEME.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

ATEME has a Current Ratio of 1.49. This is a normal value and indicates that ATEME is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.49, ATEME is in line with its industry, outperforming 47.83% of the companies in the same industry.
A Quick Ratio of 1.37 indicates that ATEME should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.37, ATEME is doing good in the industry, outperforming 60.87% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 1.37
ATEME.PA Yearly Current Assets VS Current LiabilitesATEME.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for ATEME have decreased strongly by -33.46% in the last year.
ATEME shows a decrease in Revenue. In the last year, the revenue decreased by -6.53%.
ATEME shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.11% yearly.
EPS 1Y (TTM)-33.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%527.35%
Revenue 1Y (TTM)-6.53%
Revenue growth 3Y5.87%
Revenue growth 5Y7.11%
Sales Q2Q%3.55%

3.2 Future

Based on estimates for the next years, ATEME will show a very strong growth in Earnings Per Share. The EPS will grow by 78.17% on average per year.
ATEME is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.39% yearly.
EPS Next Y147.71%
EPS Next 2Y78.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.36%
Revenue Next 2Y8.39%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ATEME.PA Yearly Revenue VS EstimatesATEME.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
ATEME.PA Yearly EPS VS EstimatesATEME.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4 -0.4 0.6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

ATEME reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 15.16, which indicates a correct valuation of ATEME.
73.91% of the companies in the same industry are more expensive than ATEME, based on the Price/Forward Earnings ratio.
ATEME is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 15.16
ATEME.PA Price Earnings VS Forward Price EarningsATEME.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ATEME indicates a slightly more expensive valuation: ATEME is more expensive than 69.57% of the companies listed in the same industry.
ATEME's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 21.72
EV/EBITDA 274.84
ATEME.PA Per share dataATEME.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

ATEME's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ATEME's earnings are expected to grow with 78.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y78.17%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ATEME!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ATEME SA

EPA:ATEME (6/19/2025, 1:20:11 PM)

4.06

+0.03 (+0.74%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)04-24 2025-04-24
Earnings (Next)07-17 2025-07-17
Inst Owners22.34%
Inst Owner ChangeN/A
Ins Owners25.61%
Ins Owner ChangeN/A
Market Cap46.65M
Analysts86
Price Target7.65 (88.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.96%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.23%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 15.16
P/S 0.5
P/FCF 21.72
P/OCF 11.92
P/B 1.39
P/tB 5.44
EV/EBITDA 274.84
EPS(TTM)-0.47
EYN/A
EPS(NY)0.27
Fwd EY6.6%
FCF(TTM)0.19
FCFY4.6%
OCF(TTM)0.34
OCFY8.39%
SpS8.14
BVpS2.92
TBVpS0.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.54%
ROE -16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57.97%
FCFM 2.3%
ROA(3y)-2.76%
ROA(5y)-1.47%
ROE(3y)-8.87%
ROE(5y)-4.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.28%
GM growth 5Y1.27%
F-Score3
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 17.15
Debt/EBITDA 92.65
Cap/Depr 42.02%
Cap/Sales 1.89%
Interest Coverage N/A
Cash Conversion 1459.7%
Profit Quality N/A
Current Ratio 1.49
Quick Ratio 1.37
Altman-Z 1.35
F-Score3
WACC5.12%
ROIC/WACCN/A
Cap/Depr(3y)51.6%
Cap/Depr(5y)53.6%
Cap/Sales(3y)2.22%
Cap/Sales(5y)2.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%527.35%
EPS Next Y147.71%
EPS Next 2Y78.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.53%
Revenue growth 3Y5.87%
Revenue growth 5Y7.11%
Sales Q2Q%3.55%
Revenue Next Year7.36%
Revenue Next 2Y8.39%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-63.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year296.71%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y236.99%
FCF growth 3YN/A
FCF growth 5Y-12.09%
OCF growth 1Y522.93%
OCF growth 3YN/A
OCF growth 5Y-6.11%